Skip to content

White Paper “Granulation &Tablet Compression TROUBLE SHOOTING GUIDE” Now Available

MEGGLE is pleased to announce the release of its new white paper,“Granulation & Tablet Compression – Trouble Shooting Guide.” This comprehensive guide provides a structured approach to troubleshooting common challenges encountered in pharmaceutical granulation and tablet compression processes. Covering wet granulation, dry granulation, and direct compression, the document links typical process-related issues to their root...

Introduction to the Nitrosamine Risk Assessment Tool

MEGGLE has launched the online tool “Nitrosamine Risk Assessment Calculator” to support nitrosamine risk assessment during pharmaceutical formulation development. ■ Key features – two complementary modules・Basic Calculator :It‘s designed for quick initial screening. The user enters the API name, tablet strength and size, and selects the manufacturing process type and amine type — both of...

The MEGGLE Group mourns the loss of Toni Meggle

The long-time owner and entrepreneur Toni Meggle passes away at the age of 94 The employees of the MEGGLE Group mourn the loss of their long-time owner, Toni Meggle, who passed away on October 30, 2025, at the age of 94. With his passing, the MEGGLE Group has not only lost an outstanding entrepreneurial figure...

Notice of Change in President of MEGGLE Japan Co., Ltd.

We would like to express our sincere appreciation for your continued support and patronage. We are pleased to announce that, effective July 1, 2025, Mr. Jun Yokomizo has been appointed Representative Director and President of MEGGLE Japan Co., Ltd. We would also like to inform you that the former Managing Director, Mr. Thomas Pilgram, stepped...

MEGGLE Excipients Website Relaunch

We are pleased to announce the relaunch of the official MEGGLE Excipients website:www.meggle-excipients.com The new website features a modern, refined design in MEGGLE’s signature blue and is fully optimized for all devices, including desktops, tablets, and smartphones. Our customer portal has also been enhanced, allowing registered users to access order history for sample requests, easily...

MicroceLac® Plus Now Available

We are pleased to announce the launch of MicroceLac® Plus, the upgraded version of our co-processed excipient MicroceLac® 100.This new product combines 35% lactose monohydrate with 65% microcrystalline cellulose, significantly enhancing tablet compressibility.Designed specifically for direct compression, MicroceLac® Plus enables the production of robust tablets with high hardness and low friability, even with challenging APIs...

Low-Nitrite Grade Lactose Now Available

In response to the growing awareness of the risks associated with nitrosamines, MEGGLE has launched three new Low-Nitrite Grade Lactose Monohydrate products.(Click here for details)These products are standardized to contain ≤0.10 ppm of nitrite in every batch.With our new Low Nitrite excipients, we offer manufacturers a trusted solution to meet regulatory requirements and improve formulation safety. <Product Lineup>・GranuLac®...

MEGGLE Sustainability Whitepaper

We understand that time is limited, and reviewing a full sustainability report may not always be feasible. That’s why we’ve created a concise whitepaper, highlighting the most crucial aspects of sustainability with a focus on our Business Unit Excipients and the pharmaceutical industry.

Lactose Monohydrate Low Endotoxin

Lactose Monohydrate Low Endotoxin is MEGGLE´s protective sieved product, which is not specified in PSD, but in microbiological quality and endotoxins. Due to the characteristics of the product, Lactose LE is suitable for use in inhalation and parenteral applications. Please do not hesitate to contact us for samples.

Compaction Blend M

Compaction Blend M is versatile and suitable for a wide range of technical applications, including: Please do not hesitate to contact us for samples.